Views & Analysis Digital Health Round-up - Is AI the future of cancer drug de... Does artificial intelligence hold the key to cancer drug R&D?
Views & Analysis Digital Health Round-up: an artificial future for diabetes A round-up of this week's digital healthcare news. Marco Ricci reports.
News CDM scoops "Best of Show" at PM Society Awards A diabetes awareness campaign from CDM London proved to be the “Best of Show” at this year’s PM Society Awards, recognising the crème de la crème in pharma marketing.
News Intarcia's under skin mini-pump accepted by FDA Device is first twice-yearly, injection-free exenatide therapy.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
